Active Pharmacovigilance and Healthcare Utilization
This study highlights the potential value of innovative ways of collecting information about adverse drug events directly from patients.
No Significant Differences Found in Breast Cancer Treatment Between MA, FFS Beneficiaries: Galen Shearn-Nance, BS
MASLD Associated With 2-Fold Increase of Serious Bacterial Infection
Health Risks of Microplastics Highlighted at Recent Medical Conferences
Nivolumab With Ipilimumab Approved by FDA for Use in Hepatocellular Carcinoma